Lee Financial CO Laboratory Corp Of America Holdings Transaction History

Lee Financial CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$197.69 - $227.29 $2,174 - $2,500	11 Added 137.5%	19 $4,000
Q3 2023 Nov 09, 2023	SELL	$201.05 - $221.7 $1,809 - $1,995	-9 Reduced 52.94%	8 $1,000
Q2 2023 Aug 08, 2023	BUY	$211.93 - $241.33 $1,907 - $2,171	9 Added 112.5%	17 $4,000
Q1 2023 May 15, 2023	SELL	$213.32 - $257.83 $41,597 - $50,276	-195 Reduced 96.06%	8 $1,000
Q4 2022 Feb 09, 2023	BUY	$203.72 - $248.97 $1,629 - $1,991	8 Added 4.1%	203 $47,000
Q3 2022 Nov 01, 2022	SELL	$204.81 - $262.19 $1,843 - $2,359	-9 Reduced 4.41%	195 $40,000
Q2 2022 Aug 10, 2022	SELL	$213.86 - $277.87 $855 - $1,111	-4 Reduced 1.92%	204 $48,000
Q1 2022 May 11, 2022	SELL	$259.82 - $298.18 $1,818 - $2,087	-7 Reduced 3.26%	208 $54,000
Q4 2021 Feb 08, 2022	BUY	$271.6 - $314.21 $1,901 - $2,199	7 Added 3.37%	215 $67,000
Q2 2021 Aug 04, 2021	BUY	$251.87 - $278.14 $52,388 - $57,853	208 New	208 $57,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.